Chandra K Khasgiwala, MD | |
160 Turnpike Rd, 2nd Floor, Chelmsford, MA 01824-4054 | |
(978) 328-1016 | |
Not Available |
Full Name | Chandra K Khasgiwala |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 160 Turnpike Rd, Chelmsford, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043434517 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 51257 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Chandra K Khasgiwala, MD 160 Turnpike Rd, 2nd Floor, Chelmsford, MA 01824-4054 Ph: (978) 328-1016 | Chandra K Khasgiwala, MD 160 Turnpike Rd, 2nd Floor, Chelmsford, MA 01824-4054 Ph: (978) 328-1016 |
News Archive
Using functional magnetic resonance imaging (fMRI) for before-and-after analysis, a team of researchers including a UC Santa Barbara graduate student discovered positive changes in brain activity in children with autism who received a particular type of behavioral therapy.
Neuralstem, Inc., a biopharmaceutical company using neural stem cell technology to develop small molecule and cell therapy treatments for central nervous system diseases, announced that the poster "Human Neural Stem Cells Expressing IGF-1: A Novel Cellular Therapy for Alzheimer's Disease" was presented yesterday at the International Society for Stem Cell Research (ISSCR) Annual Meeting in Stockholm, Sweden.
Nuvilex, Inc. announced its plans to continue development of the live-cell encapsulation technology obtained with its recent acquisition of SG Austria, to carry out the pancreatic cancer clinical trial, to maintain and expand customers utilizing the encapsulation technology, and to establish itself as an active participant in the stem cell arena. The stem cell market was estimated to be $21.5 billion globally in 2010 and is forecast to reach $63.8 billion by 2015.
Breast cancer patients treated with the chemotherapy drug Taxol (paclitaxel) are more likely to develop chronic neuropathic pain, according to research published in The Journal of Pain, the peer review publication of the American Pain Society.
› Verified 7 days ago
Eric H Stein, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3 Meeting House Rd, Ste 24, Chelmsford, MA 01824 Phone: 978-256-5557 Fax: 978-256-1835 | |
Vijay K Nayak, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3 Meeting House Rd, Suite 24, Chelmsford, MA 01824 Phone: 978-256-5557 Fax: 978-256-1835 | |
Vishnu Kannabiran, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3 Meeting House Rd, Chelmsford, MA 01824 Phone: 978-256-5557 Fax: 978-256-1835 | |
Arthur M Lauretano, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3 Meeting House Rd, Suite 24, Chelmsford, MA 01824 Phone: 978-256-5557 Fax: 978-256-1835 | |
Jessica Lauren Hootnick, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3 Meeting House Rd, Chelmsford, MA 01824 Phone: 978-256-5557 Fax: 978-256-1835 | |
Bjorn Bie, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3 Meeting House Rd, Suite 24, Chelmsford, MA 01824 Phone: 978-256-5557 Fax: 978-256-1835 |